Jubilant Life Sciences receives credit rating of ‘A1+’ from CRISIL

03 May 2017 Evaluate

Jubilant Life Sciences has received credit rating of ‘A1+’ from CRISIL for commercial paper programme of Rs 400 crore. The ratings are in addition to credit rating of 'A+' issued by India Ratings and Research on September 30, 2016 for Rs 450 crore commercial paper/ Short Term Debt Programme of the company.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

Jubilant Pharmova Share Price

944.05 -10.60 (-1.11%)
27-Jan-2026 09:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1642.15
Dr. Reddys Lab 1246.40
Cipla 1299.85
Zydus Lifesciences 892.30
Lupin 2154.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×